The ESMO magnitude of clinical benefit scaling tool: from theory to practice
- PMID: 26347102
- DOI: 10.1093/annonc/mdv367
The ESMO magnitude of clinical benefit scaling tool: from theory to practice
Comment in
-
Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.Ann Oncol. 2016 Jan;27(1):203-5. doi: 10.1093/annonc/mdv502. Epub 2015 Oct 30. Ann Oncol. 2016. PMID: 26519490 No abstract available.
Comment on
-
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).Ann Oncol. 2015 Aug;26(8):1547-73. doi: 10.1093/annonc/mdv249. Epub 2015 May 30. Ann Oncol. 2015. PMID: 26026162
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources